Nakaigawa N - Search Results

1

Neuroendocrine Carcinoma of the Bladder.

Kawahara T, Yamanaka S, Ohshiro H, Sekiguchi Z, Namura K, Itou H, Sano F, Kita K, Hayashi N, Makiyama K, Nakaigawa N, Ogawa T, Uemura H, Yao M, Kubota Y. Kawahara T, et al. Among authors: nakaigawa n. Case Rep Oncol. 2010 Mar 3;3(1):54-58. doi: 10.1159/000289584. Case Rep Oncol. 2010. PMID: 20740160 Free PMC article.

2

[Molecular genetic mechanism of the kidney cancer].

Nakaigawa N, Yao M, Kishida T, Kubota Y. Nakaigawa N, et al. Nihon Rinsho. 2001 Jan;59(1):104-9. Nihon Rinsho. 2001. PMID: 11197838 Review. Japanese.

3

Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters.

Kondo K, Yao M, Yoshida M, Kishida T, Shuin T, Miura T, Moriyama M, Kobayashi K, Sakai N, Kaneko S, Kawakami S, Baba M, Nakaigawa N, Nagashima Y, Nakatani Y, Hosaka M. Kondo K, et al. Among authors: nakaigawa n. Genes Chromosomes Cancer. 2002 May;34(1):58-68. doi: 10.1002/gcc.10054. Genes Chromosomes Cancer. 2002. PMID: 11921283

4

[High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer].

Hasumi H, Kishida T, Teranishi J, Nakaigawa N, Fujinami K, Ikeda I, Uemura H, Yao M, Takeda M, Noguchi S, Kubota Y. Hasumi H, et al. Among authors: nakaigawa n. Hinyokika Kiyo. 2002 Aug;48(8):469-73. Hinyokika Kiyo. 2002. PMID: 12243071 Free article. Japanese.

5

Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.

Yoshida M, Yao M, Ishikawa I, Kishida T, Nagashima Y, Kondo K, Nakaigawa N, Hosaka M. Yoshida M, et al. Among authors: nakaigawa n. Genes Chromosomes Cancer. 2002 Dec;35(4):359-64. doi: 10.1002/gcc.10123. Genes Chromosomes Cancer. 2002. PMID: 12378530

6

VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma.

Yao M, Yoshida M, Kishida T, Nakaigawa N, Baba M, Kobayashi K, Miura T, Moriyama M, Nagashima Y, Nakatani Y, Kubota Y, Kondo K. Yao M, et al. Among authors: nakaigawa n. J Natl Cancer Inst. 2002 Oct 16;94(20):1569-75. doi: 10.1093/jnci/94.20.1569. J Natl Cancer Inst. 2002. PMID: 12381710

7

[A novel molecular target therapeutics for refractory prostate cancer].

Uemura H, Ikeda N, Nakaigawa N, Ouchi H, Ishiguro H, Kubota Y. Uemura H, et al. Among authors: nakaigawa n. Nihon Rinsho. 2002 Dec;60 Suppl 11:272-7. Nihon Rinsho. 2002. PMID: 12599584 Review. Japanese. No abstract available.

8

Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor.

Baba M, Hirai S, Yamada-Okabe H, Hamada K, Tabuchi H, Kobayashi K, Kondo K, Yoshida M, Yamashita A, Kishida T, Nakaigawa N, Nagashima Y, Kubota Y, Yao M, Ohno S. Baba M, et al. Among authors: nakaigawa n. Oncogene. 2003 May 8;22(18):2728-38. doi: 10.1038/sj.onc.1206373. Oncogene. 2003. PMID: 12743597

9

Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor.

Uemura H, Ishiguro H, Nakaigawa N, Nagashima Y, Miyoshi Y, Fujinami K, Sakaguchi A, Kubota Y. Uemura H, et al. Among authors: nakaigawa n. Mol Cancer Ther. 2003 Nov;2(11):1139-47. Mol Cancer Ther. 2003. PMID: 14617787

10

Angiotensin II blocker decreases serum prostate specific antigen in hormone refractory prostate cancer.

Yamagishi T, Uemura H, Nakaigawa N, Noguchi K, Kubota Y. Yamagishi T, et al. Among authors: nakaigawa n. J Urol. 2005 Feb;173(2):441. doi: 10.1097/01.ju.0000148855.17830.97. J Urol. 2005. PMID: 15643197 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters